EU Data Protection Reductions Would ‘Irretrievably Sabotage’ Pharma Industry

 
• By Ian Schofield

With the proposals for an overhaul of the EU pharmaceutical legislation tentatively scheduled for publication on 29 March, the European industry federation EFPIA claims that the plans as currently drafted will drive investment away and damage the industry’s ability to compete at global scale. But the European Commission insists the revision will boost industry's global competitiveness and innovative power.

Sailboat
Getting agreement on the revision of the EU pharma legislation will not be plain sailing • Source: Shutterstock

More from Europe

More from Geography